Thermogenesis Holdings Investor Relations Material
Latest events
Q3 2023
Thermogenesis Holdings
Q1 2024
17 May, 2024
Q4 2023
16 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Thermogenesis Holdings Inc
Access all reports
ThermoGenesis Holdings, Inc. previously known as Cesca Therapeutics Inc., is a developer in automated cell processing technologies for the cell and gene therapy sector. The company, through its subsidiary ThermoGenesis Corp., offers comprehensive solutions for automated clinical biobanking, point-of-care applications, and large-scale cell processing and manufacturing, particularly for the emerging CAR-T immunotherapy market. Thermogenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California, with its shares listed on the Nasdaq stock exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
THMO
Country
🇺🇸 United States